SynthesisSystematic reviews2026
Effects of curcuminoids on allergic rhinitis diseases: a systematic review and meta-analysis of animal and human studies.
Synthesis in Systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAllergic rhinitis is a chronic inflammatory condition triggered by allergens. Curcuminoids, known for their anti-inflammatory and immunomodulatory properties, show potential as alternative treatments for allergic rhinitis. This systematic review and meta-analysis evaluated the efficacy of curcuminoids in managing allergic rhinitis symptoms and related biological markers in both animal and human studies.
methodsA systematic search of PubMed, Embase, Scopus, and Cochrane Library was conducted to identify eligible animal and human studies. Data extraction included allergic rhinitis symptom scores (rubbing, sneezing, itching, nasal congestion, and runny nose) and related biological markers (i.e., IL-4 and IgE). The risk of bias was assessed using SYRCLE's tool for animal studies and RoB2 for human studies. Meta-analyses employed a random-effects model and reported standardized mean difference (SMD) with 95% confidence intervals (CIs). Certainty of evidence was evaluated with the GRADE approach.
resultsSeven animal studies (n = 189) and three human studies (n = 371) were included in the meta-analysis. Animal studies showed significant reductions in two symptom scores and one related biological marker: rubbing (SMD = - 2.2013, 95% CI - 3.8027 to - 0.5998, p = 0.0071); sneezing (SMD = - 2.3844, 95% CI - 3.6940 to - 1.0747, p = 0.0004); and IL-4 (SMD = - 0.9416, 95% CI - 1.8130 to - 0.0702, p = 0.0342). Symptom scores in humans showed a trend toward reduction, although the change was not statistically significant.
conclusionsCurcuminoids showed beneficial effects in animal models of allergic rhinitis, while current human evidence is limited and inconclusive. Further well-designed clinical trials are needed to clarify their therapeutic potential in humans. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42025640405.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.